PUBLICATIONS
Exsure's Recent Publications
PUBLICATIONS
05/06/2024: ExoDS: a versatile exosome-based drug delivery platform to target cancer cells and cancer stem cells
11/04/2024: Nanog promotes FoxP3 expression in breast cancer stem cell that can be attenuated by aspirin treatment
01/10/2023: 678P ExoDS: A bioengineered exosome-based capsule for targeted delivery of chemotherapy drugs to cancer cells and cancer stem cells
https://www.annalsofoncology.org/article/S0923-7534(23)02701-1/fulltext
Our Abstract and Poster for ESMO - European Society for Medical Oncology Congress 2023 titled "ExoDS: A bioengineered exosome-based capsule for targeted delivery of chemotherapy drugs to cancer cells and cancer stem cells" has been published in Annals of Oncology.
26/05/2023: Neutrophils in Cancer and Potential Therapeutic Strategies Using Neutrophil-Derived Exosomest
Click Here https://pubmed.ncbi.nlm.nih.gov/37376417/
27/11/2022: Exosome-based cancer stem cell communication: Implication for detecting and eliminating cancer stem cells
04/08/2022: Advancement in exosome-based cancer therapeutics: A new era in cancer treatment
Click Here